Records containing: Human Papillomavirus (HPV) Infection

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

All FDA submission records EMA medicine records ClinicalTrials.gov record updates ClinicalTrials.gov records with results posted

CLINICAL_TRIALS study record update · 2026-02-23
Secondary Cervical Cancer Prevention of Vulnerable Women With Human Papillomavirus (HPV) and Human Immunodeficiency Virus (HIV) Co-infection in India
CLINICAL_TRIALS study record update · 2026-02-19
The Effect of Delivering HPV Education Through Different Methods on Young Women's Intention to Receive the Vaccine: A Randomized Controlled Trial
CLINICAL_TRIALS study record update · 2026-01-23
A Randomized, Open-label, Non-inferiority Phase IIIb Clinical Trial to Evaluate the Immunogenicity Age/Schedule Bridging Between Adolescent Girls Aged 9-14 Years Receiving a 2-dose Regimen or Adolescent Girls Aged 9-17 Years Receiving a 3-dose Regimen of a Quadrivalent Recombinant Human Papillomavirus (HPV) Vaccine (Hansenula Polymorpha) and Women Aged 18-35 Years.
CLINICAL_TRIALS study record update · 2025-12-18
Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine
CLINICAL_TRIALS study record update · 2024-11-26
A Phase II, Multicenter Study on the Clinical Effectiveness of Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.
Organize your saved records without ads with Plus.
CLINICAL_TRIALS study record update · 2014-03-27
Re-examination Study for General Vaccine Use to Assess the Safety Profile of GARDASIL in Usual Practice
CLINICAL_TRIALS study record update · 2011-03-24
Study to Assess the Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' HPV Vaccine GSK580299 in Healthy Female Subjects Aged 10-25 Years.